A Study of Compound Amino Acid Capsule on Maintenance Hemodialysis Patients - Trial NCT05874557
Access comprehensive clinical trial information for NCT05874557 through Pure Global AI's free database. This phase not specified trial is sponsored by RenJi Hospital and is currently Not yet recruiting. The study focuses on Hemodialysis Complication. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
RenJi Hospital
Timeline & Enrollment
N/A
Jun 01, 2023
Aug 01, 2023
Primary Outcome
Change from Baseline Serum Albumin at 3 months,Change from Baseline Serum Albumin at 6 months,Change from Baseline Serum Albumin at 9 months
Summary
The goal of this retrospective cohort study is to investigate the effects of compound amino
 acid capsule on nutrition, calcium and phosphorus metabolism in maintenance hemodialysis(MHD)
 patients. The main questions it aims to answer are:
 
 1. Can compound amino acid capsule improve the nutritional status of MHD patients?
 
 2. Can compound amino acid capsule help to correct the calcium and phosphorus metabolism
 imbalance of MHD patients?
 
 3. Is compound amino acid capsule safe for MHD patients? We will collect the medical
 history and laboratory data of MHD patients who regularly took compound amino acid
 capsule for 9 months or did not use the same preparation in previous medical experience.
 We focus on the difference of serum albumin level between the treatment group and the
 control group within 9 months, as well as prealbumin, hemoglobin, ferritin, calcium,
 phosphorus, 1,25-OH 2-D3 and intact parathyroid hormone (iPTH).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05874557
Non-Device Trial